ASRGL1 and cancer: The results showed that high expression of ASRGL1 was suggestive of poorer OS, except in patients with microvascular invasion [HR = 1.82 (0.85–3.88), P = 0.012] and that the high expression of ASRGL1 was negatively correlated with PFS in female patients and patients with stage 3, 2/3, and 3/4 cancers.